# Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

> **NCT03432156** · PHASE2 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 68 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **BIOLOGICAL:** Autologous Tcm cells immunotherapy

## Key facts

- **NCT ID:** NCT03432156
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-03
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03432156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03432156, "Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03432156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*